Anthropic celebrates a fair use victory in AI copyright law, but faces a trial over piracy claims involving seven million books. With billions in potential damages, the case could redefine AI data use and set critical precedents for the industry.
Nissan’s 2026 Armada introduces its first-ever NISMO variant, blending SUV practicality with high-performance thrills. Featuring sporty styling and enhanced power, this edition targets enthusiasts while the standard Armada offers versatility. Nissan’s bold move could reshape the full-size SUV market.
Tesla faces a four-month deadline from French regulators over misleading FSD claims, trade-in issues, and refund delays. Non-compliance could lead to hefty fines and reputational damage in a key European market, raising questions about the company’s practices.
Rep. Brittany Pettersen made waves by bringing her infant son to a congressional hearing with the Federal Reserve Chairman. Her multitasking moment highlights the challenges of balancing motherhood and public office, sparking discussions on work-life balance and the need for family-friendly policies in politics.
Hims & Hers Health Inc. is standing firm against Novo Nordisk’s demands, refusing to halt sales of affordable weight-loss shots. Despite the end of their partnership, Hims’ CEO vows to prioritize accessibility, sparking a heated debate over pricing and innovation in the pharmaceutical industry.
The housing market, once a wealth-building powerhouse, is cooling, raising fears of a sustained downturn. Rising interest rates and economic uncertainty are curbing demand, while increasing supply shifts dynamics. Experts warn of potential price declines ahead.
The S&P 500 is nearing a historic high after a strong trading session, with futures showing little change. Investor confidence, driven by solid earnings and economic data, fuels optimism, though risks linger. Will the index break records? The financial world watches closely.
Louisiana has sued CVS, alleging the pharmaceutical giant deceived customers via text messages, inflated drug prices, and undermined independent pharmacies. The lawsuit raises concerns over data privacy and market fairness, potentially setting a precedent for corporate accountability in healthcare.
The UK competition regulator is considering rules to make Google offer alternative search engines, adjust result rankings for fairness, and improve data portability. This could reshape the search market, boost competition, and empower users with more choices online.
A woman with Type 1 diabetes is insulin-free after a single dose of experimental stem cell therapy. This breakthrough offers hope for millions, potentially revolutionizing diabetes care by regenerating insulin-producing cells, though further research is needed.
